Literature DB >> 240135

The beta-adrenergic receptor-adenyl-cyclase system of rat reticulocytes: effects of adrenergic stimulants and inhibitors.

D Gauger, G Kaiser, K Quiring, D Palm.   

Abstract

Non-nucleated red blood cells from rats contain adenyl cyclase, the activity of which is predominantly localized in the reticulocytes. Basal enzyme activities in membrane preparations from reticulocyte-rich blood (pretreatment of rats with acetyl-phenylhydrazide: about 60% reticuloytes) are about 5 times higher than in preparations from reticulocyte-poor blood (untreated animals: 2-3% reticulocytes). The enzyme activities are stimulated 10-fold by sodium fluoride (10(-2)M) and 6 to 8-fold by isoprenaline (10(-4)M). Adenyl cyclase activities in membrane preparations from reticulocyte-rich and reticulocyte-poor blood can be ascribed to identical enzymes since identical apparent Km (ATP; 3 times 10(-4)M, Ka (isoprenaline; 3 times 10(-6)M) and Ki (propranolol vs. isoprenaline; 3 times 10(-7)M) values were obtained in both preparations. Besides NaF, only phenylethanolamine derivatives with beta-adrenergic receptor stimulant properties were effective as stimulators of adenyl cyclase activity. The affinities (apparent Ka values) of the investigated compounds decreased in the order isoprenaline--hexoprenaline--fenoterol--salbutamol--adrenaline--terbutalin--noradrenaline--phenylephrine. For maximal intrinsic activity, the catechol structure was essential; the relative intrinsic activities of resorcinol derivatives did not exceed 0.6. The isoprenaline-stimulated adenyl cyclase activities in erythrocyte membrane preparations were competitively inhibited by beta-adrenergic blocking drugs, the affinities (apparent Ki values) decreasing in the order prindolol--penbutolol--propranolol--practolol. The dextrorotatory enantiomers of penbutolol and propranolol were 1/100 to 1/200 as active as the resp. levorotatory enantiomers. From experiments with alpha-adrenergic agonists (e.g. phenylephrine) and antagonists (e.g. phentolamine), it is concluded that alpha-adrenergic receptors do not interfere with the beta-adrenergically-mediated cAMP formation in these particular membranes. A variety of hormones and drugs known to stimulate denyl cyclase activities in various tissues, e. g. ACTH, glucagon, STH, erythropoietin, prostaglandin E1 etc. did not affect adenyl cyclase activity in reticulocyte-rich erythrocyte membrane preparations. In contrast to adenyl cyclase activity, phosphodiesterase activities in erythrocyte membrane and cytoplasmic fractions were only twice as high in reticulocyte-rich as in reticulocyte-poor preparations. From the experiments described, it is obvious that the adenyl cyclase of the rat reticulocyte is subject to monovalent-hormonal, i.e. beta-sympathomimetic stimulation. Moreover, the premature red blood cell provides a useful model for quantitative studies of the interaction of drugs with the beta-adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240135     DOI: 10.1007/bf00508412

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  THE CELLULAR LOCATION OF ADENYL CYCLASE IN THE PIGEON ERYTHROCYTE.

Authors:  P R DAVOREN; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1963-09       Impact factor: 5.157

2.  Adenyl cylase. I. Distribution, preparation, and properties.

Authors:  E W SUTHERLAND; T W RALL; T MENON
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  Proceedings: Synthesis of cyclic AMP and cyclic AMP-mediated protein phosphorylation in rat erythrocytes.

Authors:  K Quiring; G Kaiser; D Gauger; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  The effect of norepinephrine on cyclic AMP levels in discrete regions of the developing rabbit brain.

Authors:  M J Schmidt; G A Robison
Journal:  Life Sci I       Date:  1971-04-15

5.  Adenyl cyclase in cardiac tissue.

Authors:  G I Drummond; L Duncan
Journal:  J Biol Chem       Date:  1970-03-10       Impact factor: 5.157

6.  [Molecular biologic problems in the maturation of erythrocytes].

Authors:  S Rapoport
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1968

Review 7.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

8.  Ontogenetic development of adenyl cyclase and phosphodiesterase in rat brain.

Authors:  B Weiss
Journal:  J Neurochem       Date:  1971-03       Impact factor: 5.372

9.  Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.

Authors:  H Sheppard; G Wiggan
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

10.  Quantitative determination of soluble and membrane proteins through their native fluorescence.

Authors:  K Resch; W Imm; E Ferber; D F Wallach; H Fischer
Journal:  Naturwissenschaften       Date:  1971-04
View more
  16 in total

1.  Modulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation.

Authors:  J E Brown; J W Adamson
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  Identification and quantification of beta-adrenoceptors sites in red blood cells from rats.

Authors:  G Kaiser; G Wiemer; G Kremer; J Dietz; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

3.  Effects of Mg2+, Mn2+ and Ca2+ on adenylcyclase activity. Evidence for a metallic site.

Authors:  G Wiemer; G Kaiser; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

4.  Monoamine oxidase in rat reticulocytes: subcellular localization and identification of isoenzymes.

Authors:  K Quiring; S Hubertus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

5.  Direct characterization of beta-adrenoceptors in membranes of immature red blood cells from rats.

Authors:  G Kaiser; G Wiemer; J Dietz; D Palm
Journal:  Blut       Date:  1978-12-15

6.  Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte.

Authors:  G Wiemer; A Wellstein; D Palm; H M von Hattingberg; D Brockmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

7.  Desensitization of the beta-adrenoceptor-adenylate cyclase system of immature erythrocytes by in-vivo treatment of rats with isoprenaline.

Authors:  G Wiemer; G Kaiser; J Dietz; M Reinhardt; A Wellstein; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

8.  Properties of beta-adrenoceptor sites in metabolizing and nonmetabolizing rat reticulocytes and in resealed reticulocyte ghosts.

Authors:  H Porzig; M Baer; C Chanton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981       Impact factor: 3.000

9.  Cyclic AMP-dependent protein kinases and binding sites for cyclic AMP in rat erythrocytes.

Authors:  K Quiring; G Kaiser; D Gauger; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

10.  Monoamine oxidase activity in rat erythrocytes: evidence for its localization in reticulocyte mitrochondria.

Authors:  K Quiring; G Kaiser; D Gauger
Journal:  Experientia       Date:  1976-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.